Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
RG7422
CHF 0.00
In stock
SYN-1150-M0011 mgCHF 142.00
SYN-1150-M0055 mgCHF 213.00
SYN-1150-M01010 mgCHF 355.00
SYN-1150-M05050 mgCHF 1'064.00
SYN-1150-M100100 mgINQ
Product Details | |
---|---|
Synonyms | GDC-0980 |
Product Type | Chemical |
Properties | |
Formula | C23H30N8O3S |
MW | 498.6 |
CAS | 1032754-93-0 |
Purity Chemicals | ≥95% |
Appearance | Solid. |
Solubility | Soluble in DMSO. Slightly soluble (<1mg/ml) in ethanol. |
Declaration | Manufactured by SynKinase. |
Other Product Data |
Target: PI3K | Kinase Group: Lipid Kinase | Substrate: Lipid Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
InChi Key | YOVVNQKCSKSHKT-HNNXBMFYSA-N |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
GDC-0980 (RG7422) is a selective, dual PI3 Kinase and mTOR Kinase inhibitor with IC(50) values of 5, 27, 7, and 14nM for PI3Kα-δ respectively. It inhibits mTOR with a Ki of 17nM.
Product References
- Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) for the treatment of cancer: D.P. Sutherlin, et al.; J. Med. Chem. 54, 7579 (2011)